Mary S. Barrett - Concepedia

Author

Mary S. Barrett

University of Iowa

Also Known As

MARY BARRETT, MARY S. BARRETT, Mary S Barrett, Mary S. Barrett

Publications

531

Citations

H-Index

Concepts

All Affiliations

University of Iowa Veterans Health Administration

About

Mary S. Barrett is an author at University of Iowa specializing in medicine, antimicrobial resistance, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	19	469
2	Health Sciences	5	5	111
3	Natural Sciences	2	2	73
4	Biochemistry	2	2	61
5	Cell Biology	1	1	33

Mary S. Barrett

Publications

469

Citations

H-Index

Page 1

	Year	Citations
Comparative Antimicrobial Activity and Kill-Curve Investigations of Novel Ketolide Antimicrobial Agents (HMR 3004 and HMR 3647) Tested against Haemophilus influenzae and Moraxella catarrhalis Strains Douglas J. Biedenbach, Mary S. Barrett, Ronald N. Jones Diagnostic Microbiology and Infectious Disease Antimicrobial SusceptibilityAntibioticsHmr 3647MedicineComparative Antimicrobial Activity	1998	47
In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae Ronald N. Jones, Douglas J. Biedenbach, Matthew A.T. Croco, Diagnostic Microbiology and Infectious Disease Streptococcus PneumoniaeAntimicrobial SusceptibilityKlebsiella PneumoniaeClinical InfectionRecent Clinical Isolates	1998	46
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum Ronald N. Jones, Mary S. Barrett Clinical Microbiology and Infection Bioorganic ChemistryAntimicrobial SusceptibilityAntibioticsBiochemistryNatural Sciences	1995	40
Phenotypic detection of mec A-positive staphylococcal blood stream isolates: High accuracy of simple disk diffusion tests Martin Cormican, Werner W. Wilke, Mary S. Barrett, Diagnostic Microbiology and Infectious Disease Phenotypic DetectionHigh AccuracyHealthcare-associated InfectionMicrobiologyInfection Control	1996	39
The E-Test applied to susceptibility tests of gonococci, multiply-resistant enterococci, and enterobacteriaceae producing potent β-lactamases Martha L. Sanchez, Mary S. Barrett, Ronald N. Jones Diagnostic Microbiology and Infectious Disease Potent β-LactamasesMultiply-resistant EnterococciAntimicrobial Resistance GeneAntimicrobial SusceptibilityHealth Sciences	1992	37
BAY 12-8039, a novel fluoroquinolone Douglas J. Biedenbach, Mary S. Barrett, Matthew A.T. Croco, Diagnostic Microbiology and Infectious Disease Bay 12-8039Medicinal ChemistryMedicinePathologyFluorous Synthesis	1998	37
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628 Mary S. Barrett, Ronald N. Jones, Meridith E. Erwin, Diagnostic Microbiology and Infectious Disease Medicinal ChemistryPharmaceutical ChemistryBioorganic ChemistryHealth SciencesAntibiotics	1991	35
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393) Beth M. Briggs, Ronald N. Jones, Meridith E. Erwin, Diagnostic Microbiology and Infectious Disease Medicinal ChemistryPharmaceutical ScienceMedicineNatural SciencesVitro Activity Evaluations	1991	33
Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates Frank Koontz, Meridith E. Erwin, Mary S. Barrett, Diagnostic Microbiology and Infectious Disease Antimicrobial SusceptibilityAntibioticsRapid-growing Mycobacteria IsolatesMicrobiologyInfection Control	1994	23
Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin William W. Hoover, Mary S. Barrett, Ronald N. Jones Diagnostic Microbiology and Infectious Disease Major MetabolitePharmaceutical ScienceBiochemistryAntibioticsMedicine	1992	21

Page 1